Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Hypogonadotropic Hypogonadism”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT01739595
What this trial is testing

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 181
Not applicableUnknownNCT00456274
What this trial is testing

Baselines in Reproductive Disorders

Who this might be right for
AmenorrheaHypogonadotropic HypogonadismKallmann's Syndrome
Massachusetts General Hospital 180
Testing effectiveness (Phase 2)UnknownNCT04189133
What this trial is testing

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

Who this might be right for
Acquired Hypogonadotropic Hypogonadism
Azienda Ospedaliero-Universitaria di Modena 32
Large-scale testing (Phase 3)Study completedNCT01532414
What this trial is testing

Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 151
Testing effectiveness (Phase 2)Study completedNCT02651688
What this trial is testing

A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene

Who this might be right for
Acquired Hypogonadotropic HypogonadismObesity
Repros Therapeutics Inc. 50
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT01993212
What this trial is testing

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 120
Large-scale testing (Phase 3)Study completedNCT01993225
What this trial is testing

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 120